Amneal Pharmaceuticals's total assets for Q3 2024 were $3.46B, a decrease of -1.39% from the previous quarter. AMRX total liabilities were $2.65B for the fiscal quarter, a -1.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.